GLYC Chart
See on advanced chart >
About
GlycoMimetics, Inc. is a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are...
Read More
- HighlightA late clinical-stage biotechnology company that developing glycobiology-based therapies for cancers and inflammatory diseases
- ExchangeNASDAQ
- Listing Date01/10/2014
- Established Date04/04/2003
- Full-time Employees35
- Address9708 Medical Center Drive Rockville Maryland 20850
- Tel1-240-2431201
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology